News

Rousselot said that previous in-vivo and in-vitro studies carried out with Peptan Hydrolysed Collagen and published in the March 2010 issue of ‘Bone’ have demonstrated the positive effect

Opexa said that the newly issued patents are US patent nos 7,695,713 and 7,658,926, the granted claims of which are directed to its proprietary process for manufacturing its

Amorfix has identified several disease specific epitopes (DSEs) on misfolded proteins with their proprietary ProMIS computational platform discovery technology, which will be used by Epitomics to generate highly

Galapagos and Roche have increased the number of antibody targets in the alliance. In addition, the targets can now also be used as starting points for molecules consisting

US-based Cumberland Pharma has granted an exclusive license to Phebra, an Australian based pharmaceutical company, for commercialisation of Acetadote in Australia. Phebra is now preparing for the Australian

Compugen said that in recently completed studies, CGEN-928, a membrane protein which previously had no known function or potential clinical utility, has demonstrated broad expression in human multiple

Aker BioMarine and Lipogen said that the target formula is a matrix of Lipogen PS phosphatidylserine produced from Aker BioMarine’s pure Superba Krill Oil. Reportedly, Phosphatidylserine (PS) and

Critical Outcome Technologies said that the gap analysis is conducted prior to an initial meeting with the FDA to identify potential deficiencies in the preclinical development program of

TRP-2 and gp100 are the key components of Scancell’s lead ImmunoBody vaccine for melanoma, SCIB1. As per the agreement, Scancell has agreed to pay the US Public Health